findmyKOL

Ileana Pina, MD, MPH

Enriched profile

Senior Staff Fellow, Medical Officer, US Food and Drug Administration · US Food and Drug Administration

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceNone verifiedPayments2021–2025NIH funding1998–2002

Ileana Pina is Senior Staff Fellow, Medical Officer, US Food and Drug Administration at US Food and Drug Administration. OpenAlex indexes 579 publications with 56,468 citations (h-index 101). By OpenAlex citation count, this profile ranks in the top 5% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.

Data verified 19 Oct 2026

Overview

Updated 19 Oct 2026

Ileana Pina, MD, MPH, is Senior Staff Fellow, Medical Officer, US Food and Drug Administration. The public record shows 579 publications with 56,468 citations (h-index 101), centered on Heart Failure Treatment and Management, Cardiovascular and exercise physiology, Heart rate and cardiovascular health. It also documents industry payments reported by 20 companies, 1 NIH-funded awards (1998–2002).

  • Most recent indexed publication: 2025 · Circulation. Heart failure
  • Top research focus: Heart Failure Treatment and Management
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 19 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiovascular and exercise physiologyHeart rate and cardiovascular healthCardiac Health and Mental HealthCardiovascular Function and Risk Factors

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trials—Industry payments56Publications6Leqviogeneric · InclisiranClinical trials—Industry payments9Publications—Monoferricgeneric · Ferric derisomaltoseClinical trials—Industry payments8Publications—Repathageneric · EvolocumabClinical trials—Industry payments6Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments3Publications—Mounjarogeneric · TirzepatideClinical trials—Industry payments2Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments1Publications—Kerendiageneric · FinerenoneClinical trials—Industry payments1Publications—Lokelmageneric · Sodium zirconium cyclosilicateClinical trials—Industry payments1Publications—Onpattrogeneric · PatisiranClinical trials—Industry payments1Publications—Veltassageneric · PatiromerClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim International GmbHClinical trials—Industry payments42AstraZeneca Pharmaceuticals LPClinical trials—Industry payments25Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments20Novartis Pharmaceuticals CorporationClinical trials—Industry payments12E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments9Amgen Inc.Clinical trials—Industry payments8Pharmacosmos Therapeutics Inc.Clinical trials—Industry payments8Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments7Eli Lilly and CompanyClinical trials—Industry payments3Kestra Medical Technology Services, Inc.Clinical trials—Industry payments3Roche Diagnostics International LtdClinical trials—Industry payments3Merck Sharp & Dohme LLCClinical trials—Industry payments2Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments2Roche Diagnostics CorporationClinical trials—Industry payments2Vifor Pharma, Inc.Clinical trials—Industry payments2Abbott LaboratoriesClinical trials—Industry payments1Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1AstraZeneca UK LimitedClinical trials—Industry payments1Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
579publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

56,468citations

Total citations across indexed works.

101h-index

Hirsch index (OpenAlex). i10-index 318.

Clinical & industry

trials, payments and federal funding
0clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1998–2002

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

Updated 19 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.1%
    Beta blocker14.9%
    Metoprolol Succinate73%Carvedilol15%Bisoprolol Fumarate12%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)14.6%
    Candesartan Cilexetil81%Valsartan19%
    Part D<11 patients

    + 11 more classes in this area

  • Metabolism & gastrointestinal

    10.9%
    SGLT2 inhibitor10.9%
    Farxiga61%Jardiance39%
    Part D≥22 patients
  • Blood & clotting

    8.7%
    Factor Xa inhibitor6%
    Eliquis84%Xarelto17%
    Part D<11 patients
    P2Y12 inhibitor1.7%
    Clopidogrel100%
    Part D<11 patients

    + 1 more class in this area

All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 19 Oct 2026

1 NIH research award on record, funded 1998–2002 per NIH RePORTER. The latest:

Publications

Updated 19 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 19 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Christopher M. O’Connor114David J. Whellan99Gary Michael Felker91Javed Butler83William E. Kraus72Mona Fiuzat63Kirkwood F. Adams61James L. Januzzi58Robert John Mentz53Faiez M. Zannad47Jerome L. Fleg44John A. Spertus38Dalane W. Kitzman37Gregg C. Fonarow37Steven J. Keteyian35Lawton S. Cooper33Scott David Solomon33Adrian F. Hernandez32Eric Leifer32Justin Adrian Ezekowitz29Stefan D. Anker27Gerasimos S Filippatos27MARGARET FORNEY PRESCOTT24Piotr P. Ponikowski24Daniel B. Mark24Kevin Joseph Anstrom22Mark Donahue21Frederick A. Masoudi21Mihai Gheorghiade20Clyde W. Yancy19Héctor O. Ventura19Larry A. Allen19Tariq Ahmad19Alan S. Maisel18Stephen J. Ellis18Phillip J. Schulte17Jonathan H. Ward17Gary John Balady17Adam D. DeVore17Marco Metra16

Online presence

Updated 19 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    hfsa.org/ileana-l-pina-md-mph

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Other

    professional.heart.org/en/professional-membership/national-hispanic-latino-cardiovascular-collaborative/ileana-pina

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →professional.heart.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 19 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Chair

    FIT Committee, American Heart Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hfsa.org ↗
  • Board of Directors

    National American Heart Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hfsa.org ↗
  • Guest Editor

    Heart Failure Society of America

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hfsa.org ↗
  • Editorial Board Member

    Cardiac Failure Review

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor of Medicine

    Wayne State University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Clinical Professor

    Central Michigan University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.org ↗
  • Adjunct Professor

    Case Western Reserve University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nhlbi.nih.gov ↗
  • Professor

    Department of Medicine (Cardiology), Montefiore Einstein Center for Heart and Vascular Care

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗
  • Professor

    Department of Epidemiology and Population Health, Montefiore Einstein Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.